Abnormal conduction-induced cardiomyopathy: a poorly explored entity

Area of Science:

• Cardiology
• Electrophysiology
• Cardiomyopathy Research

Background:

• Dyssynchronous biventricular activation, caused by conditions like left bundle branch block or ventricular pacing, impairs global contractility.
• This abnormal activation leads to systolic dysfunction and left ventricular remodeling, defining a unique group of cardiomyopathies.
• Existing therapies focus on correcting or mitigating left ventricular (LV) dyssynchrony to reverse cardiac damage.

Purpose of the Study:

• To review the mechanisms, prevalence, and risk factors of abnormal conduction-induced cardiomyopathies.
• To outline the diagnostic and therapeutic strategies for these conditions.
• To highlight the role of multimodal imaging and a multidisciplinary approach in patient management.

Main Methods:

• Comprehensive literature review of studies on abnormal conduction-induced cardiomyopathies.
• Analysis of mechanisms linking electrical dyssynchrony to cardiac dysfunction.
• Evaluation of current diagnostic tools and therapeutic interventions, including device-based therapies and imaging modalities.

Main Results:

• Eliminating or improving LV dyssynchrony is the primary therapeutic goal, often leading to recovery of cardiac function and geometry.
• The absence of a genetic background favors a better prognosis and functional recovery.
• Multimodal imaging and a systematic etiological definition are crucial for guiding therapy.

Conclusions:

• Abnormal conduction-induced cardiomyopathies are a distinct entity where correcting electrical dyssynchrony is key to treatment.
• A multidisciplinary, imaging-guided approach is essential for accurate diagnosis and effective, etiology-guided therapy.
• Further research is needed to address areas of uncertainty and optimize management strategies.